
About CardioFocus
CardioFocus is a Healthcare company based in Marlborough (United States) founded in 1990. Endoscopic catheter for atrial fibrillation ablation is developed. CardioFocus has raised $260.86 million across 22 funding rounds from investors including Boston Scientific, SVB and HHS. CardioFocus offers products and services including HeartLight X3 and Centauri System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is CardioFocus Inc. Its competitors include AtaCor Medical, AtriCure and Kestra Medical Technologies; 2 of its 3 listed competitors have raised funding.
Company details
CardioFocus was founded in 1990 and is headquartered in Marlborough, United States. The company operates in the medical device sector, specializing in cardiology solutions for atrial fibrillation treatment. The HeartLight Endoscopic Ablation System is utilized to enable visual guidance of laser energy for pulmonary vein isolation during procedures. Products are distributed across Europe and Australia, with FDA approval obtained for the United States market.
- Headquarters Marlborough, United States
- SectorsHealthcare
- Email••••••••
- Website cardiofocus.com
- Social LinkedIn X YouTube
- Legal Name Cardiofocus Inc.
- Total Equity Funding$260.86M (USD)
in 22 rounds
- Latest Funding Round$31.76M (USD), Series E
Feb 2023
- InvestorsBoston Scientific
& 17 more
Products & Services of CardioFocus
CardioFocus offers a comprehensive portfolio of products and services, including HeartLight X3 and Centauri System.
Provides precise laser technology for atrial fibrillation ablation procedures.
Delivers efficient PFA technology for cardiac arrhythmia management.
Apps and channels of CardioFocus
its YouTube channel CardioFocus, Inc. has 283 subscribers and 18 videos.
Videos from CardioFocus
The most watched videos on CardioFocus's YouTube channel, CardioFocus, Inc. (283 subscribers). Click a video to play it here.
More on CardioFocus, Inc..
Funding Insights of CardioFocus
CardioFocus has successfully raised a total of $260.86M across 22 strategic funding rounds. The most recent funding activity was a Series E round of $31.76 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $260.86M
- Total Rounds 22
- Last Round Series E — $31.76M
- First Round $9.6M
(Jan 2000)
- Investors Count 18
Latest 10 of 22 funding rounds of CardioFocus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | Debt – Conventional | – | – | – | |
| Feb 2023 | $31.76M | Series E | – | – | – |
| Apr 2022 | $4M | Series E | – | – | – |
| May 2019 | Debt – Conventional | – | – | ||
| May 2019 | $55M | Series E | – | – | – |
| Jun 2018 | $21M | Debt – Conventional | – | – | |
| Apr 2018 | $13M | Series E | – | – | – |
| Mar 2017 | $20M | Series E | – | – | – |
| Mar 2017 | $20.18M | Series E | – | – | – |
| May 2016 | $8M | Series E | – | – | – |
18 investors in total: 18 institutional.
Investors in CardioFocus
CardioFocus has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, SVB and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| gpb-cap.com | ||||
Early stage VC firm investing in the US and Korea | oxbio.com | Boston, United States | ||
| aurorafunds.com | ||||
Early-stage US healthcare investments are made by Accuitive Medical Ventures. | amvpartners.com | Duluth, United States | ||
| kestrelinvestments.com | ||||
Venture capital fund focused on early-stage healthcare startups | svhealthinvestors.com | Boston, United States | ||
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
First Alliance is engaged in wealth management and investment services. | 1997 | firstalliance.ch | Zurich, Switzerland | |
Limited information is provided about KBL Healthcare Ventures. | kblhealthcare.com | |||
Diversified investment management services are offered across asset classes. | 2017 | klimllc.com | New York, United States |
Investor details for CardioFocus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CardioFocus
20 people are tracked at CardioFocus (6 in leadership, 6 in board & advisors, 8 in team).
| Name | Role | Group |
|---|---|---|
Jerry Melsky | VP, Engineering | Leadership |
Steve Ogilvie | CFO | Leadership |
Scott Fletcher | VP, Finance & Administration | Leadership |
Mark Casey | VP, Operations | Leadership |
Ian Christianson | Vp, Regulatory, Quality, And Clinical Affairs | Leadership |
Lisa Hausmann | Senior Director, Clinical Affairs | Leadership |
Paul Laviolette | Chairman | Board & advisors |
Omar Amirana | Director | Board & advisors |
Charles Larsen | Director | Board & advisors |
Bruce Robertson | Director | Board & advisors |
Gwen Watanabe | Director | Board & advisors |
Patrick Wethington | Director | Board & advisors |
Christopher C. | Assistant Controller | Team |
Chris Brushett | Principal Catheter Engineer | Team |
Caleb Tshaba | Catheter Manufacturing Engineer | Team |
Danielle Peart, CPA | Controller | Team |
Hamid Massoud | Principal R&d Engineer | Team |
Daniel Lee | Sr. Manufacturing Engineer | Team |
Curtis Keohane | Senior Product Design Engineer | Team |
Pete Bell | SVP Global Business Development | Team |
Complete people profiles for CardioFocus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CardioFocus
3 dated milestones of CardioFocus across 33 years, from founding to its latest funding, stage changes and deals.
- Founded CardioFocus is founded.
- Funding First funding round of $9.6M.
- Funding Latest funding round, Series E, of $31.8M.
Competitors of CardioFocus
CardioFocus has 3 listed competitors in our database, 2 of them funded. They include AtaCor Medical, AtriCure and Kestra Medical Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atacor.com | 2014 | San Clemente, United States | $136.8M | 15 | An implantable pacemaker system is developed for cardiac pacing therapy. | |
| atricure.com | 2000 | Mason, United States | 1,874 | Cardiac ablation and occlusion devices for atrial fibrillation are provided. | ||
| kestramedical.com | 2014 | Kirkland, United States | $196M | 118 | Medical devices are developed to support cardiovascular patients at risk. |
Detailed competitors of CardioFocus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CardioFocus
The website of CardioFocus (cardiofocus.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 49.8% vs previous month
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as CardioFocus (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cardiofocus
Complete news archive for CardioFocus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CardioFocus
CardioFocus was founded in 1990 and raised its 1st funding round 10 years after it was founded.
CardioFocus is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
CardioFocus is a funded company, having raised a total of $260.86M across 22 funding rounds to date. The company's 1st funding round was a Series E of $8M, raised on Jan 2000.
CardioFocus was founded in 1990 and is headquartered in Marlborough, United States. The company operates in the medical device sector, specializing in cardiology solutions for atrial fibrillation treatment. The HeartLight Endoscopic Ablation System is utilized to enable visual guidance of laser energy for pulmonary vein isolation during procedures. Products are distributed across Europe and Australia, with FDA approval obtained for the United States market.
CardioFocus's top competitors include AtaCor Medical, AtriCure and Kestra Medical Technologies.
CardioFocus offers HeartLight X3 and Centauri System.
CardioFocus has 18 investors. Key investors include Boston Scientific, SVB, HHS, Boston University, and Oxford Finance.
CardioFocus operates through Cardiofocus Inc..
